Össur key market sales normalize during second quarter

Prosthetics manufacturer Össur has experienced significant improvements to its growth in Q2 2021, compared to the same period last year which was hugely affected by covid-19.
Photo: Össur / PR
Photo: Össur / PR
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT

Icelandic prosthetics firm Össur's key market sales have normalized during the second quarter of this year, with large growth achieved compared to the same period in 2020.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading